Renalytix

Renalytix

Biotechnology, 1460 Broadway, City, New York, 19805, United States, 51-200 Employees

renalytixai.com

  • twitter
  • LinkedIn

Who is RENALYTIX

Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosisTM for kidney health. Weve engineered a proprietary solution that successfully enable...

Read More

map
  • 1460 Broadway, New York City, New York, 19805, United States Headquarters: 1460 Broadway, New York City, New York, 19805, United States
  • 2018 Date Founded: 2018
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 7372 | NAICS Code: 513210 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from RENALYTIX

Renalytix Org Chart and Mapping

VP-Level
Employees

Joe Fraas

Regional Sales Director

Angie Helluin

Billing Reimbursement Specialist

Ada V

Executive Assistant

Julie Vickers

Senior Medical Science Liaison

Elise Wilfinger

Brand, Content and Strategy Leader (Life Sciences, Biotech, Diagnostics)

Kate Benkoczy

Manager, Health System Partnerships

Linh Dang

Data Analytics Developer

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Renalytix

Answer: Renalytix's headquarters are located at 1460 Broadway, City, New York, 19805, United States

Answer: Renalytix's official website is https://renalytixai.com

Answer: Renalytix's revenue is $25 Million to $50 Million

Answer: Renalytix's SIC: 7372

Answer: Renalytix's NAICS: 513210

Answer: Renalytix has 51-200 employees

Answer: Renalytix is in Biotechnology

Answer: Renalytix contact info: Phone number: Website: https://renalytixai.com

Answer: Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosisTM for kidney health. Weve engineered a proprietary solution that successfully enables early-stage, progression risk assessment when it counts the most. Renalytix. Right here, until kidney disease isnt.TM

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access